Correlation Between Sartorius Stedim and Quantum Genomics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sartorius Stedim and Quantum Genomics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sartorius Stedim and Quantum Genomics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sartorius Stedim Biotech and Quantum Genomics SA, you can compare the effects of market volatilities on Sartorius Stedim and Quantum Genomics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sartorius Stedim with a short position of Quantum Genomics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sartorius Stedim and Quantum Genomics.

Diversification Opportunities for Sartorius Stedim and Quantum Genomics

0.14
  Correlation Coefficient

Average diversification

The 3 months correlation between Sartorius and Quantum is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Sartorius Stedim Biotech and Quantum Genomics SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Quantum Genomics and Sartorius Stedim is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sartorius Stedim Biotech are associated (or correlated) with Quantum Genomics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Quantum Genomics has no effect on the direction of Sartorius Stedim i.e., Sartorius Stedim and Quantum Genomics go up and down completely randomly.

Pair Corralation between Sartorius Stedim and Quantum Genomics

Assuming the 90 days trading horizon Sartorius Stedim is expected to generate 397.64 times less return on investment than Quantum Genomics. But when comparing it to its historical volatility, Sartorius Stedim Biotech is 11.85 times less risky than Quantum Genomics. It trades about 0.0 of its potential returns per unit of risk. Quantum Genomics SA is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest  5.25  in Quantum Genomics SA on August 29, 2024 and sell it today you would earn a total of  1.96  from holding Quantum Genomics SA or generate 37.33% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy98.46%
ValuesDaily Returns

Sartorius Stedim Biotech  vs.  Quantum Genomics SA

 Performance 
       Timeline  
Sartorius Stedim Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sartorius Stedim Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong primary indicators, Sartorius Stedim is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Quantum Genomics 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Quantum Genomics SA are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Quantum Genomics reported solid returns over the last few months and may actually be approaching a breakup point.

Sartorius Stedim and Quantum Genomics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sartorius Stedim and Quantum Genomics

The main advantage of trading using opposite Sartorius Stedim and Quantum Genomics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sartorius Stedim position performs unexpectedly, Quantum Genomics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Quantum Genomics will offset losses from the drop in Quantum Genomics' long position.
The idea behind Sartorius Stedim Biotech and Quantum Genomics SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Other Complementary Tools

Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals